Form D · Pharmaceuticals

Sequel Pharmaceuticals Inc

San Diego, CA · CIK 0001414879

Offering snapshot reported Dec 23, 2010 · SEC filing

Reported sold
$1M
Offering amount: $9M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 21, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 23, 2010Initial$1,000,000No comparison10SEC filing
Sep 7, 2010Initial$1,367,579No comparison11SEC filing
Aug 11, 2009Initial$3,005,455No comparison12SEC filing
Oct 9, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-152498

Source: Form D, filed Dec 23, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Paul Chamberlain Executive
Stuart J.M. Collinson Director
Howard C. Dittrich Executive
Brian K. Farmer Executive
Nina Kjellson Director
David Lowe Director
Mark Murgerditchian Executive
Joseph Turner Director
Daniel K. Turner, Iii Director
Eckard Weber Director
Randall Woods Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
12790 El Camino Real Suite 300
San Diego, CA, 92130